EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer’s Disease

Hesam Khodadadi, Évila Lopes Salles iD, Sahar Emami Naeini iD, Bidhan Bhandari iD, Hannah M Rogers, Jules Gouron iD, William Meeks, Alvin V Terry, Anilkumar Pillai, Jack C Yu, John C Morgan, Kumar Vaibhav iD und 4 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hesam Khodadadi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: Cannabidiol, Alzheimer Disease, Acetylcholine, Disease Models, Animal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a challenging medical issue that requires efficacious treatment options to improve long-term quality of life. Cannabidiol (CBD) is a cannabis-derived phytocannabinoid with potential health benefits, including reports from our laboratory and others showing a therapeutic role in the pre-clinical treatment of AD; however, the mechanisms whereby CBD affects AD progression remain undefined. Innate lymphoid cells (ILCs) are recently discovered immune cells that initiate and orchestrate inflammatory responses. ILC2, a sub-class of ILCs, is proposed to have a role in cognitive function via unknown mechanisms. In this present study, we explored whether CBD ameliorates AD symptoms via the enhancement of acetylcholine (ACh), a cholinergic neurotransmitter involved in cognition that may regulate ILC2. 5xFAD mice were chronically treated by inhalation of a formulation of broad-spectrum CBD for seven months. ACh production, ILC2s profile, brain histopathology, and long-term behavior were assessed. Together, our studies showed that long-term inhalation of CBD improved cognitive function and reduced senile plaques in a murine AD model, effects that were associated with enhanced ACh production and altered ILC2s distribution within the CNS. These findings indicate that inhaled CBD could offer a cost-effective, non-invasive, and effective treatment for managing AD. The beneficial effects of CBD inhalation may be linked to increased ACh production and an altered distribution of ILC2s, highlighting the need for further research in this area.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolAlzheimer DiseaseAcetylcholineDisease Models, AnimalAnimalsMiceSignal TransductionLymphocytesMice, TransgenicBrainCognitionHumansMaleFemale

Stichwörter der Autor:innen

Alzheimer’s diseaseCBDILC2acetylcholinecannabidiolinnate lymphoid cells

Substanzen

CannabidiolAcetylcholine

Autor:innen und Institutionen

  • Department of Neurology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Center for Excellence in Research, Scholarship and Innovation (CERSI), Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • The Graduate School, Augusta University, Augusta, GA 30912, USA.
  • Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

ORCID-Profile: Évila Lopes Salles, Sahar Emami Naeini, Bidhan Bhandari, Jules Gouron, Kumar Vaibhav, Krishnan M Dhandapani, Babak Baban

Zitieren

APA

Khodadadi, H., Salles, É. L., Naeini, S. E., Bhandari, B., Rogers, H. M., Gouron, J., Meeks, W., Terry, A. V., Pillai, A., Yu, J. C., Morgan, J. C., Vaibhav, K., Hess, D. C., Dhandapani, K. M., Wang, L. P., & Baban, B. (2024). Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111764

Vancouver

Khodadadi H, Salles ÉL, Naeini SE, Bhandari B, Rogers HM, Gouron J, et al. Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111764

BibTeX
@article{Khodadadi2024,
  author = {Khodadadi, Hesam and Salles, Évila Lopes and Naeini, Sahar Emami and Bhandari, Bidhan and Rogers, Hannah M and Gouron, Jules and Meeks, William and Terry, Alvin V and Pillai, Anilkumar and Yu, Jack C and Morgan, John C and Vaibhav, Kumar and Hess, David C and Dhandapani, Krishnan M and Wang, Lei P and Baban, Babak},
  title = {Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111764}
}
Kostenlos starten →